⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Mobius Care and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Mobius Care
↗Cleveland, USA
Mobius Care is a precision medicine company founded at the Cleveland Clinic, dedicated to transforming the treatment of inflammatory bowel disease (IBD). The company leverages advanced AI, multimodal patient data, and reverse translational research to develop innovative diagnostics and therapeutics that address unmet needs in IBD.
Their primary focus includes an AI-powered digital pathology tool that analyzes H&E images to predict patient response to existing IBD therapies. Additionally, the company is developing a pipeline of therapeutics aimed at promoting mucosal healing by targeting microbial dysbiosis and specific proteins, moving beyond traditional immune suppression.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Precision Medicine / Digital Health
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Crohn's & Colitis Foundation (IBD Ventures)
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:AI-powered diagnostics, Small molecule, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Cleveland Clinic (Founding institution), Crohn's & Colitis Foundation (Investor/Partner)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Cristina Larkin - CEO
Thaddeus Stappenbeck - Founder
Hardik Patel - CBO
Scientific Founders:Thaddeus Stappenbeck, MD, Ph.D.
Board Members:Linda Li, Todd Schwarzinger
LINKS
Website:mobius.care
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Mobius Care. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.